Will use cash on books for growth, acquisitions, says Advanced Enzymes
Advanced Enzymes has seen an improvement in margins due to better product mix, forex gains and lower cost of raw materials, Mukund Kabra, Whole-Time Director said in an interview to CNBC-TV18.
Advanced Enzymes has seen an improvement in margins due to better product mix, forex gains and lower cost of raw materials, Mukund Kabra, Whole-Time Director said in an interview to CNBC-TV18.
The company has approximately Rs 200 crore of cash on books.
“Cash on books will be used for growth and acquisitions,” Kabra said.
He said the business-to-consumer (B2C) brands were seeing some growth, but business-to-business (B2B) sales have been impacted due to COVID.
He said, however, that the quarterly revenue run rate of Rs 120 crore was sustainable for the next two quarters, and that working capital cannot be tightened further.
For entire interview, watch video
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Lok Sabha elections 2024: 28% of candidates contesting in fourth phase are 'crorepatis'
May 9, 2024 4:29 PM
Free poha-jalebi to movie ticket discounts: How cities struggling with 'urban apathy' are luring voters to polling booths
May 9, 2024 3:17 PM